Leuk. Lymphoma

ISSN	1029-2403
ISSN-L	1026-8022
IUID	131b70366d9d4cef9318896bf4a883e7
Modified	2020-11-27T13:12:52.077Z
Created	2018-12-05T08:57:24.392Z

Year 2022

PubMed DOI Crossref

Familial platelet disorder due to germline exonic deletions in RUNX1: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium.

Engvall M, Karlsson Y, Kuchinskaya E, ..., Cammenga J, Baliakas P

Leuk. Lymphoma 63 (10) 2311-2320 [2022-10-00; online 2022-05-09]

PubMed DOI Crossref

Limited benefit in patients with MDS receiving venetoclax and azacitidine as a bridge to allogeneic stem cell transplantation.

Jädersten M, Boriskina K, Lindholm C, ..., Mielke S, Tobiasson M

Leuk. Lymphoma 63 (3) 755-758 [2022-03-00; online 2021-11-15]

Year 2021

PubMed DOI Crossref

A single-tube multiplex method for monitoring mutations in cysteine 481 of Bruton Tyrosine Kinase (BTK) gene in chronic lymphocytic leukemia patients treated with ibrutinib.

Maffei R, Fiorcari S, Atene CG, ..., Tagliafico E, Luppi M

Leuk. Lymphoma 62 (8) 2018-2021 [2021-08-00; online 2021-03-04]

Year 2020

PubMed DOI Crossref

Overexpression of chromatin remodeling and tyrosine kinase genes in iAMP21-positive acute lymphoblastic leukemia.

Ivanov Öfverholm I, Zachariadis V, Taylan F, ..., Nordlund J, Barbany G

Leuk. Lymphoma 61 (3) 604-613 [2020-03-00; online 2019-10-22]

Year 2019

PubMed DOI Crossref

Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in TET2, DNMT3 and CUX1 - azacitidine induces only lymphoma remission.

Tobiasson M, Pandzic T, Cavelier L, Sander B, Wahlin BE

Leuk. Lymphoma 60 (13) 3316-3319 [2019-12-00; online 2019-06-17]

Year 2018

PubMed DOI Crossref

Case studies investigating genetic heterogeneity between anatomically distinct bone marrow compartments in acute myeloid leukemia.

Ojamies PN, Kontro M, Edgren H, ..., Wolf M, Kallioniemi O

Leuk. Lymphoma 59 (12) 3002-3005 [2018-12-00; online 2018-04-04]

Year 2017

PubMed DOI Crossref

Cytotoxic T cells in chronic idiopathic neutropenia express restricted antigen receptors.

Mastrodemou S, Stalika E, Vardi A, ..., Papadaki HA, Stamatopoulos K

Leuk. Lymphoma 58 (12) 2926-2933 [2017-12-00; online 2017-05-23]

PubMed DOI Crossref

Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant therapies.

Seelig DM, Ito D, Forster CL, ..., Modiano JF, Linden MA

Leuk. Lymphoma 58 (7) 1702-1710 [2017-07-00; online 2016-12-08]

PubMed DOI Crossref

Tp53 gene p72R polymorphism in chronic lymphocytic leukemia: incidence and clinical significance amongst cases with unmutated immunoglobulin receptors.

Gemenetzi K, Galigalidou C, Vlachonikola E, ..., Hadzidimitriou A, Stamatopoulos K

Leuk. Lymphoma 58 (3) 726-728 [2017-03-00; online 2016-08-09]

Year 2015

PubMed DOI Crossref

A new piece to the stereotypy "puzzle" in chronic lymphocytic leukemia.

Rosenquist R

Leuk. Lymphoma 56 (11) 3008-3009 [2015-07-03; online 2015-07-03]

PubMed DOI Crossref

Splenic marginal-zone lymphoma: ontogeny and genetics.

Baliakas P, Strefford JC, Bikos V, ..., Stamatopoulos K, Oscier D

Leuk. Lymphoma 56 (2) 301-310 [2015-02-00; online 2014-08-19]

Year 2013

PubMed DOI Crossref

Exploring the genetic landscape in chronic lymphocytic leukemia using high-resolution technologies.

Gunnarsson R, Mansouri L, Rosenquist R

Leuk. Lymphoma 54 (8) 1583-1590 [2013-08-00; online 2013-02-28]

Year 2011

PubMed DOI Crossref

Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas.

Thomas R, Seiser EL, Motsinger-Reif A, ..., Modiano JF, Breen M

Leuk. Lymphoma 52 (7) 1321-1335 [2011-07-00; online 2011-03-07]